Inverness Medical Innovations to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9, 2008

WALTHAM, Mass., Sept. 3 Inverness MedicalInnovations, Inc. (Amex: IMA), a leading manufacturer and marketer of rapiddiagnostic products for the consumer and professional markets, today announcedthat Ron Zwanziger, Chairman, Chief Executive Officer and President, and JonRussell, Vice President, Finance, are scheduled to present at the MorganStanley Global Healthcare Unplugged Conference on Tuesday, September 9th, 2008in New York. Their presentation is scheduled for 10:55 a.m. and will be madeavailable to the public through an audio webcast accessible via Inverness'website at http://www.invmed.com/investors.cfm. A replay of the webcast willbe available via the link above for 30 days. During its presentation,Inverness may discuss and answer questions concerning business and financialdevelopments and trends. Responses to questions, as well as other mattersdiscussed during the webcast, may contain or constitute information that hasnot been disclosed previously.

For more information about Inverness Medical Innovations, please visit ourwebsite at http://www.invernessmedical.com.

By developing new capabilities in near-patient diagnosis, monitoring andhealth management, Inverness Medical Innovations enables individuals to takecharge of improving their health and quality of life. A global leader inrapid point-of-care diagnostics, Inverness' products, as well as its newproduct development efforts, focus on infectious disease, cardiology,oncology, drugs of abuse and women's health. Inverness is headquartered inWaltham, Massachusetts.

SOURCE Inverness Medical Innovations, Inc.

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...